Lutein Attenuates Cyclosporin-induced Testicular Impairment in Male Rats through Modulation of Androgenic Hormones and Enzymes
Mega Obukohwo Oyovwi, Benneth Ben‐Azu, Tesi P. Edesiri, Rotu R. Arientare, Victor Emojevwe, Eze Kingsley Nwangwa, K.E. Edje, Olusegun G. Adebayo
Abstract
Background: Male reproductive toxicity has been linked to cyclosporine, a commonly used immunosuppressive drug for the prevention of organ rejection in patients undergoing renal transplant. The goal of this study was to elucidate how lutein protects male testicles from cyclosporine-induced damage. Methods: Thirty adult male Wistar rats were randomly allotted to five groups, each with six animals. Rats in groups 1 and 2 were given saline (2 mL/kg/day p.o) and corn oil (2 mL/day p.o) respectively. Rats in groups 3 and 4 were given lutein (40 mg/kg/day p.o) and cyclosporine (40 mg/kg/p.o./day), while rats in group 5 were given a combination of cyclosporine (40 mg/kg/day p.o) and lutein (40 mg/kg/day p.o). At the end of the fourth week, sperm indices, serum hormones, testicular steroidogenic enzymes [3 and 17 beta-hydroxysteroid dehydrogenases (3ß-HSD and 17ß-HSD)] and enzyme markers of spermatogenesis [lactate dehydrogenase (LDH-X), sorbitol dehydrogenase (SDH), gamma glutamyl transferase (?-GT), acid phosphatase (ACP) and alkaline phosphatase (ALP)] were assayed. The testis of each rat was also investigated for histopathological abnormalities and germ cell count. Results: Lutein attenuated cyclosporine-induced sperm impairment. In rats treated with cyclosporine, lutein reduced LDH-X, SDH, ACP, ?-GT; raised LH, FSH, testosterone, 3ß-HSD, 17ß-HSD, ALP levels, and improved spermatogenesis. Conclusion: These results suggest that lutein attenuates cyclosporine-induced testicular impairment through modulation of androgenic hormones and enzymes.